Columbus Business First reports that Ohio State University Wexner Medical Center and Ohio State’s College of Medicine found Dr. Benjamin Segal, who will join Ohio State as the new chair of the Department of Neurology. Segal, an internationally recognized expert in MS and neuroimmunology, has directed numerous clinical trials focusing on individuals with relapsing and progressive forms of MS. National Institutes of Health (NIH) funding for his ongoing research programs tops $1.3 million, and his discoveries have contributed to scientists’ basic understanding of MS and similar diseases. The award-winning neurologist holds several patents and has been recognized as a Taubman Scholar of the A. Alfred Taubman Medical Research Institute. For the past eight years, he’s been named among the Best Doctors in America, and awarded by Best Doctors, Inc.
Segal’s work includes the discovery that the type of inflammation producing MS can vary among individuals, and that pharmaceutical regimens must be personalized to the patient. His research findings have been published in top academic journals, including The Journal of Clinical Investigation, Proceedings of the National Academy of Sciences and The Lancet Neurology.